A Phase II Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine, followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results

INTRODUCTION: Neoadjuvant chemotherapy improves survival in high-risk urothelial cancer. However, the lack of curative alternatives to cisplatin-based chemotherapy is limiting for patients with neuropathy or hearing loss. Sequential chemotherapy is also not well studied in the neoadjuvant setting. W...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Siefker-Radtke, AO, Dinney, CP, Shen, Y, Williams, DL, Kamat, AM, Grossman, HB, Millikan, RE
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828072/
https://ncbi.nlm.nih.gov/pubmed/22914978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27751
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares